跳至主要内容
临床试验/JPRN-jRCTs052230070
JPRN-jRCTs052230070招募中Unknown

ovel anticoagulation therapy using Apple Watch after catheter ablation for atrial fibrillation - Up to AF trial

Sakata Yasushi0 个研究点目标入组 50 人开始时间: 2023年7月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 22age old 至 ot applicable(—)
性别
All

入选标准

  • 1. No AF recurrence after 3 months after catheter ablation
  • 2. Patients using DOACs
  • 3. Patients using iPhone (version 8 or later, SE (second generation or later))
  • 4. CHA2DS2VASc score <= 3
  • 5. Age => 22
  • 6. Signed informed consent

排除标准

  • 1. Mechanical valve
  • 2. Severe mitral stenosis
  • 3. Cases in which anticoagulation is essential (deep venous thrombosis, intracardiac thrombus, etc.)
  • 4. Heart rate above 100 bpm at rest
  • 5. Pacemaker implantation
  • 6. Implantable cardioverter defibrillator implantation or history of lethal arrhythmias
  • 7. Post-operative cardiac transplantation
  • 8. Chronic hemodialysis
  • 9. Subjects with a history of cerebral infarction
  • 10. Patients scheduled for elective surgery during the observation period, including catheterization
  • 11. Blindness or cognitive impairment
  • 12. Other persons deemed inappropriate by the investigators

研究者

发起方
Sakata Yasushi

相似试验

ovel anticoagulation therapy using Apple Watch | 临床试验